The UK Government's response to the unfolding Covid-19 crisis was of course prominent in Chancellor Rishi Sunak's maiden Budget speech on 11 March. But there was also considerable excitement about his promises relating to UK research and development (R&D).
Investment is set to double to £22bn - an increase even over the boost outlined in a strategy revealed earlier in the year - in addition to the creation of a central research centre modelled on the Defense Advanced Research Projects Agency in the US. These headline policies were supplemented with measures to ensure more even distribution of R&D funding, which until now was strongly concentrated in the 'golden triangle' of London, Oxford, and Cambridge. As coronavirus and the efforts to fight it continue to escalate, progress on these R&D policies will likely be delayed. But it is wort...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes